Sabra Healthcare REIT, Inc. (SBRA) is a publicly traded Real Estate sector company. As of May 21, 2026, SBRA trades at $21.02 with a market cap of $5.28B and a P/E ratio of 33.39. SBRA moved +0.19% today. Year to date, SBRA is +10.38%; over the trailing twelve months it is +16.55%. Its 52-week range spans $15.60 to $21.28. Analyst consensus is buy with an average price target of $22.33. Rallies surfaces SBRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent SBRA insider activity includes FLORES JESSICA sold 15.23K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $21.02 |
| Market Cap | $5.28B |
| P/E Ratio | 33.39 |
| EPS | $0.63 |
| Dividend Yield | 0.30% |
| 52-Week High | $21.28 |
| 52-Week Low | $15.60 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $812.84M |
| Net Income | $156.02M |
| Gross Margin | 0.00% |
7 analysts cover SBRA: 0 strong buy, 2 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.33.